{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/ge-healthcare-gehc/",
 "dataUrl": "https://clearank.com/stock/ge-healthcare-gehc/data.json",
 "title": "GE HealthCare (GEHC) Stock Forecast & Price Target (2026)",
 "description": "GE HealthCare Technologies Inc. (GEHC) stock: Healthcare, Medical Devices. $28.9B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "GE HealthCare Technologies Inc. (GEHC)",
 "published": "2026-07-11T09:30:53+00:00",
 "modified": "2026-09-16T03:21:43.372+00:00",
 "generated": "2026-09-16T12:02:24.732Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "GEHC",
  "name": "GE HealthCare Technologies Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Medical Devices",
  "country": "United States",
  "website": "https://www.gehealthcare.com"
 },
 "quote": {
  "price": 64.07,
  "previousClose": 64.25,
  "change": -0.18,
  "changePercent": -0.28,
  "open": 64.2,
  "high": 64.635,
  "low": 63.61,
  "volume": 4174332,
  "averageVolume": 3085423,
  "marketCap": 28939538165,
  "fiftyTwoWeekHigh": 89.77,
  "fiftyTwoWeekLow": 58.75,
  "marketOpen": false,
  "asOf": "2026-09-16T03:21:43.000Z"
 },
 "statistics": {
  "pe": 14.804147,
  "eps": 4.34,
  "dividendYield": 0.0021851100463062692,
  "beta": 0.821,
  "priceToSales": 1.3646591,
  "priceToBook": 2.6442506,
  "revenueTtm": 21265999872,
  "grossMargin": 0.4115980355119003,
  "returnOnEquity": 0.19376
 },
 "technicals": {
  "rsi": 4.28,
  "macd": -1.55,
  "sma50": 68.26,
  "sma200": 72.42,
  "rsiSignal": "Oversold",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 74,
  "consensus": "Buy",
  "fairValue": 83,
  "analystTarget": 83,
  "analystCount": 19,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-16T03:21:43.000Z",
  "priceAtAnalysis": 64.07,
  "volatility": {
   "daily": 1.28,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 62.79,
  "aggressiveEntry": 64.07,
  "stopLoss": 60.72,
  "stopLossPercent": 3.3,
  "targets": [
   65.93,
   69.07,
   72.21
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 42.99,
    "base": 65.85,
    "upside90th": 100.87
   },
   {
    "year": 2028,
    "downside10th": 37.02,
    "base": 67.67,
    "upside90th": 123.7
   },
   {
    "year": 2029,
    "downside10th": 33.23,
    "base": 69.55,
    "upside90th": 145.59
   },
   {
    "year": 2030,
    "downside10th": 30.46,
    "base": 71.48,
    "upside90th": 167.74
   },
   {
    "year": 2031,
    "downside10th": 28.31,
    "base": 73.47,
    "upside90th": 190.66
   },
   {
    "year": 2032,
    "downside10th": 26.56,
    "base": 75.5,
    "upside90th": 214.62
   },
   {
    "year": 2033,
    "downside10th": 25.11,
    "base": 77.6,
    "upside90th": 239.83
   },
   {
    "year": 2034,
    "downside10th": 23.87,
    "base": 79.75,
    "upside90th": 266.46
   },
   {
    "year": 2035,
    "downside10th": 22.8,
    "base": 81.97,
    "upside90th": 294.64
   },
   {
    "year": 2036,
    "downside10th": 21.87,
    "base": 84.24,
    "upside90th": 324.52
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "GEHC Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$64.20",
    "Day Range": "$63.61 to $64.64",
    "Prev Close": "$64.25",
    "Volume": "4.17M",
    "52-Week Range": "$58.75 to $89.77",
    "Market Cap": "$28.94B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a notable discount to sector peers (-54%), which may indicate undervaluation or specific company headwinds."
   ]
  },
  {
   "id": "financials",
   "title": "GEHC Financial Performance",
   "text": [
    "Analysis: In the last 2 quarters, GEHC beat estimates 1 times. The stock rose 1 times the next day. Price tends to react positively to beats."
   ]
  },
  {
   "id": "analysis",
   "title": "GEHC Analysis",
   "text": [
    "GE HealthCare Technologies Inc. (GEHC) is currently trading below its 50-day and 200-day moving averages ($68.26 and $72.42), signaling a bearish trend. The Relative Strength Index (RSI) is at an oversold level of 4.28, suggesting a potential for a bounce, though momentum indicators like MACD remain negative. Key support levels are not clearly defined due to the oversold RSI, but the current price of $64.07 is approaching previous lows. Volume has been above average recently, indicating increased trading activity. The chart structure suggests that a sustained move above the 50-day SMA would be required to signal a shift in the short-term trend.",
    "Insiders have made net purchases totaling $6.4 million, indicating a moderate level of confidence in the company's future performance.",
    "The median analyst price target for GEHC is $83.00, representing a potential 29.5% upside from the current price of $64.07.",
    "The current RSI of 4.28 is in oversold territory, which historically can precede a price rebound.",
    "GEHC is trading below its 50-day and 200-day moving averages ($68.26 and $72.42), indicating a prevailing bearish trend.",
    "The base case scenario for GE HealthCare Technologies Inc. (GEHC) anticipates a recovery towards its median analyst target price of $83.00 over the next 6-12 months, driven by its solid fundamentals and attractive valuation. The company's consistent profitability and moderate insider buying provide a foundation for potential upside. Upside catalysts include a sustained technical breakout above key moving averages and continued positive earnings surprises. Conversely, a failure to overcome current technical resistance or increased competitive intensity could lead to a downside scenario, potentially testing lower support levels around $30.46 as indicated by long-range projections."
   ],
   "lists": {
    "ProTips": [
     "Insider buying totaling $6.4 million suggests a moderate level of confidence from management in GE HealthCare Technologies Inc. (GEHC)'s future prospects.",
     "GEHC's oversold RSI of 4.28 indicates a potential short-term buying opportunity, but confirmation through a sustained move above its 50-day SMA ($68.26) is advised.",
     "Consider the competition in medical devices; while GEHC is currently undervalued, innovation and market share shifts could impact its long-term trajectory."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Moderate Insider Buying Signal",
     "text": "Insiders have made net purchases totaling $6.4 million, indicating a moderate level of confidence in the company's future performance.",
     "source": "Insider Trading Data"
    },
    {
     "type": "Bullish",
     "title": "Analyst Price Target Upside",
     "text": "The median analyst price target for GEHC is $83.00, representing a potential 29.5% upside from the current price of $64.07.",
     "source": "Wall Street Analysts"
    },
    {
     "type": "Bullish",
     "title": "Oversold RSI Suggests Potential Reversal",
     "text": "The current RSI of 4.28 is in oversold territory, which historically can precede a price rebound.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bearish",
     "title": "Bearish Technical Trend",
     "text": "GEHC is trading below its 50-day and 200-day moving averages ($68.26 and $72.42), indicating a prevailing bearish trend.",
     "source": "Technical Analysis"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "GE HealthCare Technologies Inc. (GEHC) demonstrates solid fundamentals, with a net profit margin of 9.33% and an operating margin of 14.98%, exceeding its return on equity of 19.38%. The company's price-to-sales ratio stands at 1.36, which is significantly lower than the sector average of 3.7, indicating a potentially undervalued stock. The debt-to-equity ratio of 0.94 is in line with the sector average, suggesting a manageable debt load. While revenue growth has been modest at 5.8%, the company's profitability and valuation metrics present a strong case for investment, especially when considering the analyst price targets that suggest considerable upside.",
    "GE HealthCare Technologies Inc. (GEHC) recently reported earnings for the quarter ending June 2026, with an EPS of $2.84, slightly beating the estimate of $2.80 by 1.43%. This positive surprise was accompanied by a significant price increase of 12.15%. The prior quarter's earnings showed a slight miss, but the overall trend indicates consistent profitability and the ability to meet or exceed analyst expectations, supporting the current 'Buy' consensus.",
    "The primary risk for GE HealthCare Technologies Inc. (GEHC) is its current bearish technical positioning, trading significantly below key moving averages with an oversold RSI. Competitive pressures within the medical devices sector could also impact future growth and profitability. Additionally, any failure to meet forward-looking revenue growth estimates of approximately 5% could dampen investor sentiment."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "28.94B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "14.80"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "4.34"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.22%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "89.77"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "58.75"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Oversold SMA Cross Bearish Price vs SMA Bearish MACD Bearish Moving averages show a lagging Death Cross (50-day: $68.26, 200-day: $72.42), price is trading below the 50-day SMA, RSI at 4.3 suggests oversold conditions; potential bounce setup."
   ],
   "facts": {
    "RSI": "Oversold",
    "SMA Cross": "Bearish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "4.28"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-1.55"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "68.26"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "72.42"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.51",
    "Correlation with Nasdaq 100 (QQQ)": "+0.40",
    "Correlation with Bitcoin (BTC)": "-0.02",
    "Correlation with Gold (XAU)": "+0.06"
   }
  },
  {
   "id": "trade-plans",
   "title": "GEHC Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (4.3) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$65.93",
    "TARGET 2": "$69.07",
    "TARGET 3": "$72.21",
    "STOP LOSS": "$60.72"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+1.36%",
    "Average Feb return": "+9.26%",
    "Average Mar return": "-6.60%",
    "Average Apr return": "-13.98%",
    "Average May return": "+2.02%",
    "Average Jun return": "+2.90%",
    "Average Jul return": "+2.62%",
    "Average Aug return": "+1.24%",
    "Average Sep return": "+4.60%",
    "Average Oct return": "-2.44%",
    "Average Nov return": "+1.13%",
    "Average Dec return": "+3.00%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.28%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in GEHC in July 2023 would be worth about $8,275 today, compared with about $16,627 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in GEHC today could grow to about $13,148 by 2036 in the base case, with a bull case near $50,651 and a bear case around $3,413. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "GEHC Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $71.48 for GEHC by 2030 in the base case, from $64.07 today (1.1x over 4 years). The downside path ends near $30.46. These are outcomes of a Monte Carlo simulation run on GEHC's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using GEHC's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "GEHC simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$42.99",
        "$65.85",
        "$101"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$37.02",
        "$67.67",
        "$124"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$33.23",
        "$69.55",
        "$146"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$30.46",
        "$71.48",
        "$168"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$28.31",
        "$73.47",
        "$191"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$26.56",
        "$75.50",
        "$215"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$25.11",
        "$77.60",
        "$240"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$23.87",
        "$79.75",
        "$266"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$22.80",
        "$81.97",
        "$295"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$21.87",
        "$84.24",
        "$325"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "TEM Tempus AI Inc NASDAQ $68.85 +10.67%",
     "url": "https://clearank.com/stock/tempus-ai-tem/"
    },
    {
     "text": "NTRA Natera, Inc. NASDAQ $350.78 +2.63%",
     "url": "https://clearank.com/stock/natera-ntra/"
    },
    {
     "text": "FBRX Forte Biosciences, Inc. NASDAQ $76.99 +0.00%",
     "url": "https://clearank.com/stock/fbrx-stock-analysis/"
    },
    {
     "text": "CVS CVS Health Corporation NYSE $94.49 -1.11%",
     "url": "https://clearank.com/stock/cvs-health-cvs/"
    },
    {
     "text": "TMO Thermo Fisher Scientific Inc. NYSE $635.29 +3.53%",
     "url": "https://clearank.com/stock/tmo-stock-analysis/"
    },
    {
     "text": "IDXX IDEXX Laboratories, Inc. NASDAQ $510.73 +0.23%",
     "url": "https://clearank.com/stock/idxx-stock-analysis/"
    },
    {
     "text": "CAPR Capricor Therapeutics, Inc. NASDAQ $8.56 -2.84%",
     "url": "https://clearank.com/stock/capr-stock-analysis/"
    },
    {
     "text": "NEOG Neogen Corp. NASDAQ $12.25 +2.51%",
     "url": "https://clearank.com/stock/neogen-neog/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "DAL vs UAL Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/dal-vs-ual/"
    },
    {
     "text": "SMH vs SOXX Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/smh-vs-soxx/"
    },
    {
     "text": "Gold vs Silver Analysis and Targets Head-to-head analysis →",
     "url": "https://clearank.com/compare/gold-vs-silver/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "GEHC Insider Trading Analysis",
   "facts": {
    "Bought": "$6.4M",
    "Sold": "None",
    "Insiders": "21",
    "Avg Transaction": "$802.9K"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in GEHC",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "May 15, 2024",
       "cells": [
        "MAKELA JAN Officer",
        "Sell",
        "87.2K",
        "$7.1M"
       ]
      },
      {
       "label": "Mar 14, 2023",
       "cells": [
        "MAKELA JAN Officer",
        "Sell",
        "70.6K",
        "$5.5M"
       ]
      },
      {
       "label": "Aug 14, 2024",
       "cells": [
        "STACHERSKI KENNETH ROBERT Officer",
        "Sell",
        "19.0K",
        "$1.6M"
       ]
      },
      {
       "label": "Jul 31, 2023",
       "cells": [
        "O'NEILL KEVIN MICHAEL Officer",
        "Sell",
        "15.6K",
        "$1.2M"
       ]
      },
      {
       "label": "Nov 6, 2024",
       "cells": [
        "ROTT ROLAND Officer",
        "Sell",
        "3.6K",
        "$309.3K"
       ]
      },
      {
       "label": "May 28, 2024",
       "cells": [
        "KASS-HOUT TAHA Chief Technology Officer",
        "Sell",
        "3.3K",
        "$259.7K"
       ]
      },
      {
       "label": "Aug 7, 2024",
       "cells": [
        "WESTRICK THOMAS J Officer",
        "Sell",
        "2.8K",
        "$222.1K"
       ]
      },
      {
       "label": "Jun 8, 2023",
       "cells": [
        "ROTT ROLAND Officer",
        "Sell",
        "2.5K",
        "$191.3K"
       ]
      },
      {
       "label": "Feb 18, 2025",
       "cells": [
        "NEWCOMB GEORGE A. Officer",
        "Sell",
        "2.0K",
        "$185.1K"
       ]
      },
      {
       "label": "Nov 5, 2024",
       "cells": [
        "RACKLIFFE PHILIP Chief Executive Officer",
        "Sell",
        "900",
        "$78.9K"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=GE+HealthCare+Technologies+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is GE HealthCare Technologies Inc. (GEHC) stock a buy right now?",
   "answer": "GE HealthCare Technologies Inc. (GEHC) is currently rated a 'Buy' by analysts, with a median price target of $83.00, suggesting a 29.5% upside from its current price of $64.07. Insider activity also indicates a moderate buy signal, with significant net purchases by insiders."
  },
  {
   "question": "What is GEHC's stock price forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, GE HealthCare Technologies Inc. (GEHC) has a base case price projection of $71.48 for 2030, with a downside scenario of $30.46 and an upside scenario of $167.74. These are statistical outcomes, not guarantees."
  },
  {
   "question": "How does GEHC's valuation compare to its sector peers?",
   "answer": "GE HealthCare Technologies Inc. (GEHC) trades at a P/E ratio of 14.80 and a price-to-sales ratio of 1.36, which are significantly lower than the sector medians of 31.9 and 3.7, respectively, indicating a potentially attractive valuation."
  },
  {
   "question": "What are the key technical indicators for GEHC stock?",
   "answer": "GEHC's technical indicators show it is trading below its 50-day and 200-day moving averages ($68.26 and $72.42), with an oversold RSI at 4.3. This suggests bearish short-term momentum, but also potential for a reversal."
  },
  {
   "question": "What is the recent earnings performance of GEHC?",
   "answer": "GEHC recently reported an EPS beat for the quarter ending June 2026, with actual EPS of $2.84 versus an estimate of $2.80, leading to a 12.15% stock price increase. This follows a slight miss in the previous quarter."
  },
  {
   "question": "What are the main risks facing GE HealthCare Technologies Inc. (GEHC)?",
   "answer": "Key risks for GEHC include its current bearish technical trend, potential competitive pressures in the medical devices market, and the possibility of not meeting projected revenue growth targets."
  },
  {
   "question": "What is the consensus rating among Wall Street analysts for GEHC?",
   "answer": "Wall Street analysts have a consensus 'Buy' rating for GEHC, with 10 'Buy' ratings and 5 'Hold' ratings out of 19 total analysts. The average analyst price target is $82.50, with a median of $83.00."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "TEM",
    "name": "Tempus AI Inc NASDAQ",
    "price": "$68.85",
    "change": "+10.67%",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "NTRA",
    "name": "Natera, Inc. NASDAQ",
    "price": "$350.78",
    "change": "+2.63%",
    "url": "https://clearank.com/stock/natera-ntra/"
   },
   {
    "ticker": "FBRX",
    "name": "Forte Biosciences, Inc. NASDAQ",
    "price": "$76.99",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/fbrx-stock-analysis/"
   },
   {
    "ticker": "CVS",
    "name": "CVS Health Corporation NYSE",
    "price": "$94.49",
    "change": "-1.11%",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "TMO",
    "name": "Thermo Fisher Scientific Inc. NYSE",
    "price": "$635.29",
    "change": "+3.53%",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "name": "IDEXX Laboratories, Inc. NASDAQ",
    "price": "$510.73",
    "change": "+0.23%",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "CAPR",
    "name": "Capricor Therapeutics, Inc. NASDAQ",
    "price": "$8.56",
    "change": "-2.84%",
    "url": "https://clearank.com/stock/capr-stock-analysis/"
   },
   {
    "ticker": "NEOG",
    "name": "Neogen Corp. NASDAQ",
    "price": "$12.25",
    "change": "+2.51%",
    "url": "https://clearank.com/stock/neogen-neog/"
   }
  ],
  "comparisons": [
   {
    "ticker": "DAL vs UAL Comparison",
    "name": "",
    "url": "https://clearank.com/compare/dal-vs-ual/"
   },
   {
    "ticker": "SMH vs SOXX Comparison",
    "name": "",
    "url": "https://clearank.com/compare/smh-vs-soxx/"
   },
   {
    "ticker": "Gold vs Silver Analysis and Targets",
    "name": "",
    "url": "https://clearank.com/compare/gold-vs-silver/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "DEO",
    "text": "Diageo plc Sponsored",
    "url": "https://clearank.com/stock/deo-stock-analysis/"
   },
   {
    "ticker": "KMB",
    "text": "Kimberly-Clark Corporation",
    "url": "https://clearank.com/stock/kmb-stock-analysis/"
   },
   {
    "ticker": "IAUM",
    "text": "iShares Gold Trust Micro",
    "url": "https://clearank.com/etf/iaum-etf-analysis/"
   },
   {
    "ticker": "SLVR",
    "text": "Sprott Silver Miners & Physical Silver ETF",
    "url": "https://clearank.com/etf/slvr-etf-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "RAY/USD",
    "text": "↓ 9.20%",
    "url": "https://clearank.com/crypto/raydium-ray-usd/"
   },
   {
    "ticker": "EGLD/USD",
    "text": "↓ 9.14%",
    "url": "https://clearank.com/crypto/egld-usd-crypto-analysis/"
   },
   {
    "ticker": "SBET",
    "text": "↓ 8.96%",
    "url": "https://clearank.com/stock/sharplink-sbet/"
   },
   {
    "ticker": "CAVA",
    "text": "↓ 8.93%",
    "url": "https://clearank.com/stock/cava-group-cava/"
   },
   {
    "ticker": "ARB/USD",
    "text": "↑ 19.42%",
    "url": "https://clearank.com/crypto/arbitrum-arb-usd/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "BSX",
    "text": "Boston Scientific Corporation",
    "url": "https://clearank.com/stock/boston-scientific-bsx/"
   },
   {
    "ticker": "DXCM",
    "text": "DexCom",
    "url": "https://clearank.com/stock/dxcm-stock-analysis/"
   },
   {
    "ticker": "EW",
    "text": "Edwards Lifesciences Corporation",
    "url": "https://clearank.com/stock/ew-stock-analysis/"
   },
   {
    "ticker": "MDT",
    "text": "Medtronic plc",
    "url": "https://clearank.com/stock/medtronic-mdt/"
   },
   {
    "ticker": "NEOG",
    "text": "Neogen Corporation",
    "url": "https://clearank.com/stock/neogen-neog/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/GEHC-ge-healthcare-gehc-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/GEHC-ge-healthcare-gehc-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "GE HealthCare (GEHC) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/ge-healthcare-gehc/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/ge-healthcare-gehc/",
        "name": "GE HealthCare (GEHC) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/ge-healthcare-gehc/#webpage",
     "url": "https://clearank.com/stock/ge-healthcare-gehc/",
     "name": "GE HealthCare (GEHC) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-11T09:30:53+00:00",
     "dateModified": "2026-09-16T03:21:43+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/GEHC-ge-healthcare-gehc-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/ge-healthcare-gehc/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/ge-healthcare-gehc/#richSnippet",
     "headline": "GE HealthCare (GEHC) Stock Forecast & Price Target (2026)",
     "name": "GE HealthCare (GEHC) Stock Forecast & Price Target (2026)",
     "description": "GE HealthCare Technologies Inc. (GEHC) stock: Healthcare, Medical Devices. $28.9B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-07-11T09:30:53+00:00",
     "dateModified": "2026-09-16T03:21:43+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "GE HealthCare Technologies Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "GEHC"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NASDAQ"
       }
      ],
      "description": "GE HealthCare Technologies Inc. is a global medical technology and diagnostics company that develops imaging systems, ultrasound equipment, patient monitoring and anesthesia solutions, and pharmaceutical diagnostics products. Its portfolio supports hospitals, health systems, and clinical providers w",
      "tickerSymbol": "GEHC",
      "sameAs": "https://www.gehealthcare.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/ge-healthcare-gehc/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/GEHC-ge-healthcare-gehc-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/ge-healthcare-gehc/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is GE HealthCare Technologies Inc. (GEHC) stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "GE HealthCare Technologies Inc. (GEHC) is currently rated a 'Buy' by analysts, with a median price target of $83.00, suggesting a 29.5% upside from its current price of $64.07. Insider activity also indicates a moderate buy signal, with significant net purchases by insiders."
     }
    },
    {
     "@type": "Question",
     "name": "What is GEHC's stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, GE HealthCare Technologies Inc. (GEHC) has a base case price projection of $71.48 for 2030, with a downside scenario of $30.46 and an upside scenario of $167.74. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "How does GEHC's valuation compare to its sector peers?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "GE HealthCare Technologies Inc. (GEHC) trades at a P/E ratio of 14.80 and a price-to-sales ratio of 1.36, which are significantly lower than the sector medians of 31.9 and 3.7, respectively, indicating a potentially attractive valuation."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key technical indicators for GEHC stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "GEHC's technical indicators show it is trading below its 50-day ($68.26) and 200-day ($72.42) moving averages, with an oversold RSI of 4.28. This suggests bearish short-term momentum, but also potential for a reversal."
     }
    },
    {
     "@type": "Question",
     "name": "What is the recent earnings performance of GEHC?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "GEHC recently reported an EPS beat for the quarter ending June 2026, with actual EPS of $2.84 versus an estimate of $2.80, leading to a 12.15% stock price increase. This follows a slight miss in the previous quarter."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks facing GE HealthCare Technologies Inc. (GEHC)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks for GEHC include its current bearish technical trend, potential competitive pressures in the medical devices market, and the possibility of not meeting projected revenue growth targets."
     }
    },
    {
     "@type": "Question",
     "name": "What is the consensus rating among Wall Street analysts for GEHC?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Wall Street analysts have a consensus 'Buy' rating for GEHC, with 10 'Buy' ratings and 5 'Hold' ratings out of 19 total analysts. The average analyst price target is $82.50, with a median of $83.00."
     }
    }
   ]
  }
 ]
}